| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-14 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-14 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-12 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-12 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-11 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |